Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al
- PMID: 32503850
- DOI: 10.1136/annrheumdis-2020-218070
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al
Keywords: arthritis, rheumatoid; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.Ann Rheum Dis. 2020 Oct;79(10):1382-1383. doi: 10.1136/annrheumdis-2020-217717. Epub 2020 May 12. Ann Rheum Dis. 2020. PMID: 32398281 No abstract available.
-
COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases.Ann Rheum Dis. 2021 Apr;80(4):e50. doi: 10.1136/annrheumdis-2020-218008. Epub 2020 Jun 5. Ann Rheum Dis. 2021. PMID: 32503860 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical